Interim Chief Financial Officer, Corporate Senior Vice President, and Chief Accounting Officer · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Michael Knell

FY2025 is the first fiscal year CompBrief holds for Michael Knell as a named executive officer of CHARLES RIVER LABORATORIES INTERNATIONAL; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$2,107,684

6th of 6 named executive officers at Charles River Laboratories International by FY2025 total.

6 named officers on file for CHARLES RIVER LABORATORIES INTERNATIONAL, FY2025

See an example →

What this number hides

The filing gives the total. CHARLES RIVER LABORATORIES INTERNATIONAL’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed March 31, 2026 (DEF 14A).

Free

Get Michael Knell’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Michael Knell and every company like it: Velarion Intel, free for 3 days, no card →

Michael Knell compensation by year

CHARLES RIVER LABORATORIES INTERNATIONAL Summary Compensation Table · the one fiscal year held
In US dollars, as CHARLES RIVER LABORATORIES INTERNATIONAL reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$448,118
Bonus$30,000
Stock awards$1,195,459
Option awards$0
Non-equity incentive$347,500
Pension and deferred compensation$0
All other$86,607
Total$2,107,684

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. DEF 14A filed March 31, 2026, accession 0001104659-26-037367, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed document, accession 0001104659-26-037367. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU8,197$1,669,401—
RSU6,698$1,364,115—

Per the Outstanding Equity Awards at Fiscal Year-End table in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

CHARLES RIVER LABORATORIES INTERNATIONAL’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
James FosterChair, President and Chief Executive Officer$15,435,220
Birgit GirshickCorporate Executive Vice President, Chief Operating Officer$5,898,392
Joseph LaPlumeCorporate Executive Vice President, Corporate Development & Strategy$3,513,345
Victoria CreamerCorporate Executive Vice President and Chief People Officer$3,332,387
Flavia PeaseCorporate Executive Vice President, Chief Financial Officer$2,952,695
Michael Knell · this pageInterim Chief Financial Officer, Corporate Senior Vice President, and Chief Accounting Officer$2,107,684

The full CHARLES RIVER LABORATORIES INTERNATIONAL compensation record

free company brief

This page is one person within CHARLES RIVER LABORATORIES INTERNATIONAL's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the CHARLES RIVER LABORATORIES INTERNATIONAL proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order CHARLES RIVER LABORATORIES INTERNATIONAL's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CHARLES RIVER LABORATORIES INTERNATIONAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order CRL

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Michael Knell's compensation dossier